| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.047 | 0.3 |